Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.
about
A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functionsAngiomotin is a novel Hippo pathway component that inhibits YAP oncoproteinRegulation of localization and function of the transcriptional co-activator YAP by angiomotin.Amot recognizes a juxtanuclear endocytic recycling compartment via a novel lipid binding domainAngiomotins link F-actin architecture to Hippo pathway signaling.PIV5 M protein interaction with host protein angiomotin-like 1Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Angiomotin Family Members: Oncogenes or Tumor Suppressors?Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos.Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesisThe vasculome of the mouse brain.Angiomotin functions in HIV-1 assembly and budding.Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis.Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumorsThe Amotl2 gene inhibits Wnt/β-catenin signaling and regulates embryonic development in zebrafishExercise training and peripheral arterial disease.Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.The Angiomotins--from discovery to function.Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).The E-cadherin/AmotL2 complex organizes actin filaments required for epithelial hexagonal packing and blastocyst hatching.Angiostatin inhibits activation and migration of neutrophils.Gestational age-related patterns of AMOT methylation are revealed in preterm infant endothelial progenitors.The switches.ELM resource: a compendium of conditional regulatory interaction interfaces.Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats?The polarity protein Angiomotin p130 controls dendritic spine maturation.Novel linear motif filtering protocol reveals the role of the LC8 dynein light chain in the Hippo pathway.AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility.The physiological role of Motin family and its dysregulation in tumorigenesis.Early prediction of revascularisation by angiomotin-targeting positron emission tomography
P2860
Q24299493-8020B7C9-DAEE-4BD8-919D-B55A7340DBFFQ24323326-FDB0F1F6-2E5F-4DB2-A82A-D9A4D4D17BD5Q30352874-413874EA-1C7F-4A0A-A4F5-2BCD4012261BQ30494045-05646A54-F905-4E69-ADFD-CAA652EBF839Q33604410-0DAFEEB3-E31B-452B-9BD0-DFF93EA1D565Q33621090-7EC088C7-1D2C-41D8-8497-C9C2FC1F9470Q33786788-CC620A06-7250-43A0-AC58-C77EA04CA29FQ33837277-F640D887-C9E2-45BD-865C-E881E9B17345Q34207272-15BF0342-567C-476D-BEA2-E38891E2EC81Q34326616-FD7FDAB7-9858-44E4-8496-506469E099AFQ34352631-DDBE2984-85C9-4342-B533-ACAFD0C414A1Q34376255-B95802C7-DCDA-4F30-B194-E86F697935FAQ34534371-03AAA736-3917-4E4E-9BF5-D23A7FB9FB37Q35111541-662F92AA-9659-43FD-8668-5F7914B190EBQ35562536-B7087A07-7212-4868-974A-E6E4E48960A5Q35576534-14E42488-D8C1-4BB0-A3B4-1D3DD989AFE9Q35918770-738EBCFD-2569-43B5-909E-72E040A330B2Q35921664-7E343C65-8D07-4970-A4F6-BDAB8101EE6BQ37157213-2F2E6047-D849-4484-9614-26B66ED793E7Q37415683-902DF475-F1E1-4993-9879-52E25DF3A264Q37705796-EC69E549-6520-4982-BE15-9A1B5E41FF60Q38189166-F4703829-D91F-4689-9BD3-C8D5047D2999Q38941672-0A0150E3-CCF5-4154-B01B-1F5CFBB47671Q38976675-02063E23-553C-4CEB-A42B-249D08F946B6Q41529348-BC40142F-2436-4873-B41A-6E02E8408CC8Q42631171-AA598DD5-DB90-44D4-BC2A-6F2E5776712BQ42696297-BEAEE392-1975-4162-8E98-88351246C292Q44549934-1C7244B7-C5E8-4F34-B6C6-BEC90FF6D700Q45958188-2FF92FC0-D47A-4F0E-9B84-7A124F7E4B44Q47215747-7965E9B8-44E1-4FCE-A0AE-C1558A2B1552Q47294135-A56EE274-EC2A-4B1E-B525-12086E256256Q48151146-98587692-0092-4147-99A6-D4BDF636A4F1Q52591394-010C3DFE-70E5-4202-B196-1F0B5C74C0B7Q59138135-05F6C76A-F839-4C82-8175-C0D72AD82D9A
P2860
Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Differential roles of p80- and ...... lization of endothelial cells.
@ast
Differential roles of p80- and ...... lization of endothelial cells.
@en
Differential roles of p80- and ...... lization of endothelial cells.
@nl
type
label
Differential roles of p80- and ...... lization of endothelial cells.
@ast
Differential roles of p80- and ...... lization of endothelial cells.
@en
Differential roles of p80- and ...... lization of endothelial cells.
@nl
prefLabel
Differential roles of p80- and ...... lization of endothelial cells.
@ast
Differential roles of p80- and ...... lization of endothelial cells.
@en
Differential roles of p80- and ...... lization of endothelial cells.
@nl
P2093
P1476
Differential roles of p80- and ...... lization of endothelial cells.
@en
P2093
Indranil Sinha
Karin Aase
Lars Holmgren
Mira Ernkvist
Niina Veitonmaki
Olivier Birot
Staffan Nyström
P304
P356
10.1016/J.BBAMCR.2007.11.018
P407
P577
2007-12-08T00:00:00Z